2-Methoxyisobutylisonitrile probe during parathyroid surgery: tool or gadget?

Area of Science:

• Nuclear Medicine
• Endocrine Surgery
• Oncology

Background:

• Parathyroid surgery success relies on complete tumor removal.
• Technetium-99m-labeled 2-methoxyisobutylisonitrile (MIBI) is a radiotracer that parathyroid tumors retain.
• A hand-held gamma probe can detect MIBI for intraoperative localization.

Purpose of the Study:

• To evaluate the clinical value of intraoperative gamma probe detection using MIBI in parathyroid surgery.
• To compare the outcomes of nuclear-guided parathyroidectomy with conventional exploration.

Main Methods:

• A case-control study involving 62 patients undergoing nuclear-guided parathyroidectomy and 60 patients undergoing conventional parathyroid exploration.
• Assessment of MIBI probe sensitivity in single and multiple gland parathyroid disease.
• Comparison of surgical success rates, complication rates (hypoparathyroidism, recurrent laryngeal nerve injury).

Main Results:

• MIBI probe sensitivity was 84.6% for single-gland disease and 63.0% for multiple-gland disease.
• Surgical success rates were similar between the nuclear-guided and conventional surgery groups.
• Rates of temporary/permanent hypoparathyroidism and recurrent laryngeal nerve injury were comparable in both groups.

Conclusions:

• The MIBI gamma probe is a potentially valuable tool for identifying parathyroid tumors during surgery.
• Despite its utility in localization, the MIBI probe did not lead to improved clinical outcomes in parathyroid surgery at this institution.
• Further studies may be needed to optimize the integration of nuclear guidance into parathyroidectomy protocols.